Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Recruiting · NCT06613100 · Registry updated 2026-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 | 2026-07-31 | NCT06613100 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amgen | 180 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Carolina Urologic Research Center | Myrtle Beach | United States | 55 |
| Fred Hutchinson Cancer Center | Seattle | United States | 5 |
| Medical College of Wisconsin | Milwaukee | United States | 483 |
| The Ohio State University | Columbus | United States | 191 |
| Thomas Jefferson University | Philadelphia | United States | 165 |
| Universitaetsklinikum Essen | Essen | Germany | 60 |
| Universitaetsklinikum Hamburg Eppendorf | Hamburg | Germany | 14 |
| University of California San Francisco | San Francisco | United States | 144 |
| Washington University | St Louis | United States | 182 |